Stearic acid protects primary cultured cortical neurons against oxidative stress

Acta Pharmacologica Sinica

Volumn 28, Issue 3, 2007, Pages 315-326

  Wang, Ze Jian ^a   Liang, Cui Ling ^b   Li, Guang Mei ^a   Yu, Cai Yi ^a   Yin, Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Antioxidants; Neurons; Oxidative stress; Peroxisome proliferator activated; Receptors

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CATALASE; CYCLOHEXIMIDE; ETHER DERIVATIVE; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SODIUM AZIDE; STEARIC ACID; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; BRAIN LEVEL; BRAIN NERVE CELL; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DIAGNOSTIC KIT; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; ENZYME RELEASE; LIPID PEROXIDATION; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HYDROGEN PEROXIDE; LIGANDS; LIPID PEROXIDATION; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PPAR GAMMA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SODIUM AZIDE; STEARIC ACIDS;

EID: 33847183532     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00512.x     Document Type: Article

References (32)

1. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F. Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 1999; 40: 1371-83.
2. Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 1979; 76: 944-8.
3. Bazan NG. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 2005; 32: 89-103.
4. Baer DJ, Judd JT, Kris-Etherton PM, Zhao G, Emken EA. Stearic acid absorption and its metabolizable energy value are minimally lower than those of other fatty acids in healthy men fed mixed diets. J Nutr 2003; 133: 4129-34.
5. Monsma CC, Ney DM. Interrelationship of stearic acid content and triacylglycerol composition of lard, beef tallow and cocoa butter in rats. Lipids 1993; 28: 539-47.
6. Tholstrup T, Marckmann P, Jespersen J, Sandstrom B. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr 1994; 59: 371-7.
7. Brune S, Kolsch H, Ptok U, Majores M, Schulz A, Schlosser R, et al. Polymorphism in the peroxisome proliferators activated receptor alpha gene influences the risk for Alzheimer's disease. J Neural Transm 2003; 110: 1041-50.
8. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 1998; 161: 978-84.
9. Wang ZJ, Li GM, Tang WL, Yin M. Neuroprotective effects of the stearic acid against toxicity of oxygen/glucose deprivation or glutamate on rat cortical or hippocampal neurons. Acta Pharmacol Sin 2006; 27: 145-50.
10. + dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress. Brain Res 2001; 922: 21-9.
11. Zhou LJ, Song W, Zhu XZ, Chen ZL, Yin ML, Cheng XF. Protective effects of bilobalide on amyloid beta-peptide 25-35-induced PC12 cell cytotoxicity. Acta Pharmacol Sin 2000; 21: 75-9.
12. Song Y, Wei EQ, Zhang WP, Zhang L, Liu JR, Chen Z. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport 2004; 15: 2181-4.
13. Pereira MP, Hurtado O, Cardenas A, Alonso-Escolano D, Bosca L, Vivancos J. The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke. J Neuropathol Exp Neurol 2005; 64: 797-805.
14. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-568.
15. Caccamo D, Campisi A, Curro M, Li GV, Vanella A, Ientile R. Excitotoxic and post-ischemic neurodegeneration: involvement of transglutaminases. Amino Acids 2004; 27: 373-9.
16. Auger C, Attwell D. Fast removal of synaptic glutamate by postsynaptic transporters. Neuron 2000; 28: 547-58.
17. Schousboe A. Transport and metabolism of glutamate and GABA in neurons and glial cells. Int Rev Neurobiol 1981; 22: 1-45.
18. Satoh T, Ishige K, Sagara Y. Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps. Neurosci Lett 2004; 371: 1-5.
19. Nicholls DG. Mi tochondr ial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med 2004; 29: 149-77.
20. Ho YS, Magnenat JL, Gargano M, Cao J. The nature of antioxidant defense mechanisms: a lesson from transgenic studies. Environ Health Perspect 1998; 106: 1219-28.
21. Sutherland BA, Rahman RM, Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem 2006; 17: 291-306.
22. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006; 97: 1634-58.
23. Filipovic D, Radojcic MB. CuZn superoxide dismutase in the hippocampus and brain cortex of rats exposed to various stress conditions. Ann N Y Acad Sci 2005; 1048: 366-8.
24. Lontz W, Sirsjo A, Liu W, Lindberg M, Rollman O, Torma H. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha. Free Radic Biol Med 1995; 18: 349-55.
25. Wayman NS, Hattori Y, McDonald MC, Filipe HM, Cuzzocreas S, Pisano B, et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size. FASEB J 2002; 16: 1027-40.
26. Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Bécuwe P, et al. PPARγ-ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am J Physiol Cell Physiol 2005; 282: C125-33.
27. Kwak BR, Myit S, Mulhaupt F, Veillard N, Rufer N, Roosnek E, et al. PPARγ but not PPARα ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells. Circ Res 2002; 90: 356-62.
28. Shimazu T, Inoue I, Araki N, Asano Y, Sawada M, Furuya D, et al. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 2005; 36: 353-9.
29. Girnun GD, Domann FE, Moore SA, Robbins ME. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 2002; 16: 2793-801.
30. Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, et al. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 2005; 130: 325-37.
31. Raikwar HP, Muthian G, Rajasingh J, Johnson C, Bright JJ. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis. J Neuroimmunol 2005; 167: 99-107.
32. Uauy R, Castillo C. Lipid requirements of infants: implications for nutrient composition of fortified complementary foods. J Nutr 2003; 133: 2962S-72S.